Novo Nordisk is asking a court to immediately block Eli Lilly's weight loss drug ads

Novo Nordisk is requesting a court to block Eli Lilly's advertisements for Zepbound and Mounjaro, alleging the ads use outdated data and fail to mention newer, higher-dose versions of Wegovy and Ozempic.